ICU MEDICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 95.77 USD | -1.17% |
|
-2.47% | -3.98% |
Presenter SpeechShu Wang (Analysts)Okay. I certainly have my eyes focused on the prize. All ri...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.
Calendar
2024-05-05
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
95.77
USD
Average target price
142.2
USD
Spread / Average Target
+48.53%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.98% | 2.33B | |
| -2.53% | 186B | |
| -3.52% | 106B | |
| +5.33% | 50.39B | |
| +16.43% | 47.65B | |
| -1.73% | 39.29B | |
| +5.66% | 27.24B | |
| -2.01% | 25.42B | |
| +9.84% | 24.39B | |
| -1.87% | 24.54B |
- Stock Market
- Equities
- ICUI Stock
- News ICU Medical, Inc.
- Transcript : ICU Medical, Inc. Presents at Morgan Stanley 15th Annual Global Healthcare Conference, Sep-11-2017 02
